Text size: AAA

Perspectives on Prostate Disease: Volume 2, Issue 2

Did you know?

You can get instant online access to all of the articles from Volume 2 Issue 2 of Perspectives on Prostate Disease for only $25.00.

If you want a button/link to remove the box (not sure if you do or not...), it would look like this: Cancel

Already a subscriber to this newsletter? Login for complete instant access.

Articles in this issue:

Strong bones, healthy heart

Harvard experts discuss the impact that hormone therapy can have on bones and cardiovascular health.

The value of support groups: A patient's story

Cancer survivor and support group leader Stanley Klein talks about the success of his organization and explains why talking with other prostate cancer patients can be beneficial.

Radiation therapy in the spotlight (Part 2 of 2)

In Part 2 of this two-part roundtable discussion, three Harvard experts talk about the financial motivations that some physicians may have in recommending one form of radiation therapy over another.

Ask the doctor

Answers to your questions on prostate health. In this edition: the connection between the drug Flomax and cataract surgery, and the different types of PSA and their associated tests.

Advances and breakthroughs in prostate disease

A roundup of recent advances in the understanding and treatment of prostate disease.

Searching PubMed in five easy steps

Brief instructions for using the PubMed database to read more detailed information about studies cited in Perspectives on Prostate Disease.

A healthy diet of facts

A message from Editor in Chief Marc Garnick, M.D. about the role of nutrition in preventing prostate disease, and previews of other articles in this issue.

Eating for prostate health (Part 1 of 2)

Two registered dietitians from Harvard-affiliated hospitals tout the benefits of fruits, vegetables, and whole grains.

Promising technologies for the treatment of prostate cancer

Editor in Chief Marc Garnick, M.D., discusses cryotherapy, HIFU, and focal therapies, and explains why traditional treatments for prostate cancer will be around for a while.